Literature DB >> 18218782

Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP.

M Emdadul Haque1, Kelly J Thomas, Cheryl D'Souza, Steve Callaghan, Tohru Kitada, Ruth S Slack, Paul Fraser, Mark R Cookson, Anurag Tandon, David S Park.   

Abstract

PTEN-induced putative kinase 1 (Pink1) is a recently identified gene linked to a recessive form of familial Parkinson's disease (PD). The kinase contains a mitochondrial localization sequence and is reported to reside, at least in part, in mitochondria. However, neither the manner by which the loss of Pink1 contributes to dopamine neuron loss nor its impact on mitochondrial function and relevance to death is clear. Here, we report that depletion of Pink1 by RNAi increased neuronal toxicity induced by MPP(+). Moreover, wild-type Pink1, but not the G309D mutant linked to familial PD or an engineered kinase-dead mutant K219M, protects neurons against MPTP both in vitro and in vivo. Intriguingly, a mutant that contains a deletion of the putative mitochondrial-targeting motif was targeted to the cytoplasm but still provided protection against 1-methyl-4-phenylpyridine (MPP(+))/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced toxicity. In addition, we also show that endogenous Pink1 is localized to cytosolic as well as mitochondrial fractions. Thus, our findings indicate that Pink1 plays a functional role in the survival of neurons and that cytoplasmic targets, in addition to its other actions in the mitochondria, may be important for this protective effect.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18218782      PMCID: PMC2234210          DOI: 10.1073/pnas.0705363105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Pathogenesis of nigral cell death in Parkinson's disease.

Authors:  Serge Przedborski
Journal:  Parkinsonism Relat Disord       Date:  2005-06       Impact factor: 4.891

2.  Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity.

Authors:  D Offen; P M Beart; N S Cheung; C J Pascoe; A Hochman; S Gorodin; E Melamed; R Bernard; O Bernard
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

3.  Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance.

Authors:  Jeffrey P MacKeigan; Leon O Murphy; John Blenis
Journal:  Nat Cell Biol       Date:  2005-05-01       Impact factor: 28.824

4.  Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability.

Authors:  Alexandra Beilina; Marcel Van Der Brug; Rili Ahmad; Sashi Kesavapany; David W Miller; Gregory A Petsko; Mark R Cookson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-11       Impact factor: 11.205

5.  Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin.

Authors:  Jeehye Park; Sung Bae Lee; Sungkyu Lee; Yongsung Kim; Saera Song; Sunhong Kim; Eunkyung Bae; Jaeseob Kim; Minho Shong; Jin-Man Kim; Jongkyeong Chung
Journal:  Nature       Date:  2006-05-03       Impact factor: 49.962

6.  Parkin enhances mitochondrial biogenesis in proliferating cells.

Authors:  Yukiko Kuroda; Takao Mitsui; Makoto Kunishige; Masayuki Shono; Masashi Akaike; Hiroyuki Azuma; Toshio Matsumoto
Journal:  Hum Mol Genet       Date:  2006-01-31       Impact factor: 6.150

7.  Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis.

Authors:  Li Zhang; Mika Shimoji; Bobby Thomas; Darren J Moore; Seong-Woon Yu; Neena I Marupudi; Reidun Torp; Ingeborg A Torgner; Ole P Ottersen; Ted M Dawson; Valina L Dawson
Journal:  Hum Mol Genet       Date:  2005-06-08       Impact factor: 6.150

8.  Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y.

Authors:  Hao Deng; Joseph Jankovic; Yi Guo; Wenjie Xie; Weidong Le
Journal:  Biochem Biophys Res Commun       Date:  2005-10-06       Impact factor: 3.575

9.  Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations.

Authors:  Agnes Petit; Toshitaka Kawarai; Erwan Paitel; Nobuo Sanjo; Mary Maj; Michael Scheid; Fusheng Chen; Yongjun Gu; Hiroshi Hasegawa; Shabnam Salehi-Rad; Linda Wang; Ekaterina Rogaeva; Paul Fraser; Brian Robinson; Peter St George-Hyslop; Anurag Tandon
Journal:  J Biol Chem       Date:  2005-08-02       Impact factor: 5.157

Review 10.  Oxidative mechanisms in nigral cell death in Parkinson's disease.

Authors:  P Jenner
Journal:  Mov Disord       Date:  1998       Impact factor: 10.338

View more
  112 in total

1.  Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease.

Authors:  R K Dagda; A M Gusdon; I Pien; S Strack; S Green; C Li; B Van Houten; S J Cherra; C T Chu
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

2.  Pink1 kinase and its membrane potential (Deltaψ)-dependent cleavage product both localize to outer mitochondrial membrane by unique targeting mode.

Authors:  Dorothea Becker; Judith Richter; Maja A Tocilescu; Serge Przedborski; Wolfgang Voos
Journal:  J Biol Chem       Date:  2012-04-30       Impact factor: 5.157

3.  PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis.

Authors:  Ravi S Akundi; Lianteng Zhi; Hansruedi Büeler
Journal:  Neurobiol Dis       Date:  2011-09-16       Impact factor: 5.996

Review 4.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

Review 5.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

6.  Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum.

Authors:  R Pattarini; Y Rong; C Qu; J I Morgan
Journal:  Neuroscience       Date:  2008-07-08       Impact factor: 3.590

7.  Differential roles of GluN2A- and GluN2B-containing NMDA receptors in neuronal survival and death.

Authors:  Brendan Lujan; Xiaoxuan Liu; Qi Wan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26

8.  Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease.

Authors:  Adam L Orr; Florentine U Rutaganira; Daniel de Roulet; Eric J Huang; Nicholas T Hertz; Kevan M Shokat; Ken Nakamura
Journal:  Neurochem Int       Date:  2017-04-20       Impact factor: 3.921

9.  Loss of PINK1 attenuates HIF-1α induction by preventing 4E-BP1-dependent switch in protein translation under hypoxia.

Authors:  William Lin; Natasha L Wadlington; Linan Chen; Xiaoxi Zhuang; James R Brorson; Un Jung Kang
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

Review 10.  The PINK1/Parkin pathway: a mitochondrial quality control system?

Authors:  Alexander J Whitworth; Leo J Pallanck
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.